The DRAGON IMI project [1], which launched in 2020 with the aim of using artificial intelligence (AI) and machine learning to support precise coronavirus diagnosis and prognosis, has developed a prototype app to inform health professionals about existing predictive models for COVID-19 related risk assessment.
The app has been developed as part of Work Package (WP) 6 and 2, which aims to create a tool that fosters patient empowerment through decision support systems, such as the app, to optimise care.
Developed by MedC2 in collaboration with the Department of Precision Medicine from Maastricht University, the MyPatientCheck app for health professionals can be tested now. The app is still in the development stage and is not certified yet as a medical device, therefore user feedback on the prototype platform is welcome.
The DRAGON project is also progressing on WP 3, focusing on the development of a tool for rapid scalable radiological diagnosis using machine learning models. WP 3 coordinators will use an AI analysis software called CAD4COVID-CT, developed by Thirona, to assess the severity of COVID-19 infection on chest CT scans, detecting COVID-19 related abnormalities in the lungs as well as emphysema.
The AI tool is intended to aid in a more precise diagnosis of COVID-19 disease and to predict disease progression and recovery.
Learn more about the DRAGON IMI project
[1] This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005122. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. For more information, please visit: https://www.imi.europa.eu/
ERS and the European Lung Foundation are DRAGON project partners. Learn more about EU projects.